Stockreport

Amarin slips 3% on bearish coverage [Seeking Alpha]

Acasti Pharma, Inc. - Class A  (ACST) 
Last acasti pharma, inc. - class a earnings: 2/14 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: acastipharma.com/investors
PDF Amarin slips 3% on bearish coverage Oppenheimer initiates Amarin (NASDAQ: AMRN whopping 70% downside Among the negative items: The 12-month stream of late-stage competit [Read more]